Current therapeutic approaches for patients with myelodysplastic syndromes-Reference-Cited by-同舟云学术

Current therapeutic approaches for patients with myelodysplastic syndromes

Published:2010-05 Issue: Volume: Page:no-no
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Greenberg Peter L.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2010.08226.x/fullpdf

Reference106 articles.

1. Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion, results of a phase 2 study;Adès;Blood,2009

2. Levels of soluble HLA-I and beta2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome, association with clinical behavior and outcome of induction therapy;Albitar;Leukemia,2007

3. Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology;Alessandrino;Haematologica,2002

4. WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome, a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO);Alessandrino;Blood,2008

5. Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation, a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO);Alessandrino;Haematologica,2009

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials;Blood;2019-03-07

2. Development of a new knock-in mouse model and evaluation of pharmacological activities of lusutrombopag, a novel, nonpeptidyl small-molecule agonist of the human thrombopoietin receptor c-Mpl;Experimental Hematology;2018-03

3. Total coumarins of Hedyotis diffusa induces apoptosis of myelodysplastic syndrome SKM-1 cells by activation of caspases and inhibition of PI3K/Akt pathway proteins;Journal of Ethnopharmacology;2017-01

4. Evaluación Económica de Lenalidomida (Revlimid®) Para el Tratamiento Del Síndrome Mielodisplásico Con Deleción 5q de Riesgo Bajo/Intermedio-1;Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish;2017-01

5. Artesunate induces apoptosis through caspase-dependent and -independent mitochondrial pathways in human myelodysplastic syndrome SKM-1 cells;Chemico-Biological Interactions;2014-08